Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum

Finviz2026/03/12 11:03

By:Finviz

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

BURLINGTON, Mass., March 12, 2026 -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will participate in The Stifel 2026 Virtual CNS Forum being held March 17-18, 2026.

The Stifel 2026 Virtual CNS Forum
Format:	Company presentation
Day/Time:	Wednesday, March 18 at 8.30 AM ET
Webcast:	Webcast Link:

If you are interested in a virtual meeting with the Minerva team during the conference, please reach out to your Stifel representative.

A replay of the presentation will be available on the Company's Investors & Media Events and Presentations webpage for ninety days following the event.

About Minerva Neurosciences

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva is initiating a confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia. For more information, please visit the Company’s website.

Contacts:
Investor inquiries:

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum

You may also like

Crypto prices